Point of Care Diagnostics Market Size, Share, Scope, Forecast Report 2026 to 2035
What is Point of Care Diagnostics Market Size?
Point of Care Diagnostics Market Size is valued at USD 16.25 Billion in 2025 and is predicted to reach USD 38.87 Billion by the year 2035 at a 9.60% CAGR during the forecast period for 2025-2034.
Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products (PT/INR, ACT/APTT), Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Thyroid-Stimulating Hormone Testing Products, Fecal Occult Testing Products, Other Products), By Mode of Purchase, By Technology, By Sample Type, By End User, Region, And Segment Forecasts, 2026 to 2035.
Point of Care Diagnostics Market Key Takeaways:
|
Point-Of-Care diagnostic devices are used for early and quick diagnosis of diseases. These techniques are highly sensitive, cost-effective, and produce immediate results. Point-of-care diagnostics have many advantages in the physician’s office, home healthcare, research laboratory, and in the hospital. One of the major factors responsible for the growth of this market are the rising prevalence of chronic and infectious diseases all over the world. Moreover, the COVID-19 pandemic has significantly affected the point of care diagnostics market. An increasing number of COVID-19 patients forcing the healthcare industry to develop rapid and advance testing tools, driving the opportunities for POC market.
High prevalence of infectious diseases, rising human health issues, need for rapid diagnostics, lack of advanced technologies in the diagnostic labs, growing preference for home healthcare, new inventions and innovations by key players, changes in lifestyle patterns, and increasing healthcare expenditure will create more opportunities to expand the point of care diagnostics market during the forecast period.
Market Segmentation
The point of care diagnostics market can be segmented on the basis of products, Platform, mode of purchase, technology, sample type, end-users, and region. Firstly, the Product segment consists of Glucose Monitoring Products (Strips, Meters, Lancets & Lancing Devices), Cardiometabolic Monitoring Products (Cardiac Marker Testing, Blood Gas/Electrolyte Testing, HbA1c Testing), Infectious Disease Testing Products (Respiratory Infection Testing [Influenza, Tuberculosis, Others], Healthcare-Associated Infection Testing, Tropical Disease Testing, Sexually Transmitted Disease Testing [HIV, Hepatitis, Syphilis, HPV, Chlamydia, Gonorrhea, Herpes], Clostridium difficile Infection Testing, Other Infectious Disease Testing), Coagulation Monitoring Products (PT/INR, ACT/APTT), Pregnancy & Fertility Testing Products (Pregnancy, Fertility), Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-of-Abuse Testing Products, Thyroid-Stimulating Hormone Testing Products, Fecal Occult Testing Products, Other Products). According to the Mode of Purchase, the market is further divided into Prescription-Based Testing Products, OTC Testing Products. Whereas, By Technology, the overall market is again subdivided into Biochemistry, Immunoassays, Molecular Diagnostics (RT-PCR, INAAT). The Sample Type segment comprises Blood Samples, Nasal & Oropharyngeal Swabs, Urine Samples, Other Samples. Whereas, the End User segment includes Home Care Settings & Self-Testing, Clinical Laboratories, Hospitals/Critical Care/Urgent Care Centers, Ambulatory Care Facilities & Physician Offices, and Other End Users.
Based On Product, The Glucose Monitoring Products Segment Is A Major Contributor to The Market.
The glucose monitoring category constitutes the largest portion of the point-of-care diagnostics market, primarily due to the rising prevalence of diabetes globally. The global prevalence of diabetes among millions of patients underscores the necessity for continuous glucose monitoring via regular blood glucose assessments, hence supporting the demand for reliable, accurate, and user-friendly glucose testing instruments. The improvement of technology, precision, user-friendliness, and cost are pivotal elements that enhance the adoption rates of glucose monitoring systems by both patients and healthcare practitioners.
According To The Technology Category The Biochemistry Segment Dominated The Point Of Care Diagnostics Market
In 2024, biochemistry constituted the predominant segment of the point-of-care diagnostics market. Biochemical markers, including glucose, electrolytes, and lipids, must be assessed for chronic disorders such as kidney diseases, diabetes, and cardiovascular disease, which create substantial demand for biochemistry technology. Biochemistry-based point-of-care devices are favored for their simplicity, rapidity, and cost-efficiency in clinical and home-care environments. Furthermore, smaller analyzers enhanced the accuracy and utility of the items, hence augmenting their demand.
North America is expected to dominate the POC diagnostics market due to the growing prevalence of chronic and infectious diseases, and rising government initiatives in this region.
In 2024, North America led the market because to its robust healthcare infrastructure and accessibility to advanced diagnostic technology. Lifestyle diseases, such diabetes, are prevalent and have therefore heightened the demand for immediate, point-of-care testing options. The region benefits from robust government programs for research and product innovation, as well as regulatory clearances for the development of innovative point-of-care diagnostic technologies with extensive uptake.
Competitive Landscape
Some of The Key Players in The Point of Care Diagnostics Market:
- Abbott Laboratories
- Dickinson, And Company (Bd)
- Chembio Diagnostic Systems, Inc.
- Danaher Corporation
- Ekf Diagnostics Holdings Plc
- Werfenlife, S.A.
- Johnson & Johnson Services, Inc.
- Nova Biomedical
- Hoffmann-La Roche Ltd.
- Sekisui Chemical Co. Ltd.
- Quidel Corporation
- Siemens Ag
- Trinity Biotech
- Accubiotech Co., Ltd.
- Other Key Players
The Point of Care Diagnostics Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 16.25 Billion |
| Revenue Forecast In 2035 | USD 38.87 Billion |
| Growth Rate CAGR | CAGR of 9.60% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By Mode of purchase, Technology, Sample type, By End-Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., Johnson & Johnson Services, Inc., Hoffmann-La Roche Ltd., Sekisui Chemical Co. Ltd., Dickinson, And Company (Bd), Quidel Corporation, Siemens Ag, Trinity Biotech, Accubiotech Co., Ltd., and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Point of Care Diagnostics Market Segmentation
Global Point of Care Diagnostics Market Based on Products
- Glucose Monitoring Products
- Glucose Monitoring Strips
- Glucose Monitoring Meters
- Glucose Monitoring Lancets & Lancing Devices
- Cardiometabolic Monitoring Products
- Cardiac Marker Testing Products
- Blood Gas/Electrolyte Testing Products
- HbA1c Testing Products
- Infectious Disease Testing Products
- Respiratory Infection Testing Products
- Influenza Testing Products
- Tuberculosis
- Other Respiratory Infections
- Healthcare-Associated Infection Testing Products
- Tropical Disease Testing Products
- Sexually Transmitted Disease Testing Products
- HIV Testing Products
- Hepatitis Testing Products
- Syphilis Testing Products
- Human Papillomavirus Testing Products
- Chlamydia trachomatis Testing Products
- Neisseria gonorrhoeae Testing Products
- Herpes Simplex Virus Testing Products
- Clostridium difficile Infection Testing Products
- Other Infectious Disease Testing Products
- Coagulation Monitoring Products
- PT/INR Testing Products
- ACT/APTT Testing Products
- Pregnancy & Fertility Testing Products
- Pregnancy Testing Products
- Fertility Testing Products
- Tumor/Cancer Marker Testing Products
- Urinalysis Testing Products
- Cholesterol Testing Products
- Hematology Testing Products
- Drugs-of-Abuse Testing Products
- Thyroid-Stimulating Hormone Testing Products
- Fecal Occult Testing Products
- Other Products
Global Point of Care Diagnostics Market Based on Mode of Purchase
- Prescription-Based Testing Products
- Over-the-Counter (OTC) Testing Product
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Technology
-
- Biochemistry
- Immunoassays
- Molecular Diagnostics
- RT-PCR
- INAAT
Global Point of Care Diagnostics Market Based on Sample Type
- Blood Samples
- Nasal & Oropharyngeal Swabs
- Urine Samples
- Other Samples
Global Point of Care Diagnostics Market Based on End-users
- Home Care/Self Testing
- Physician offices & Outpatient/Ambulatory Care Settings
- Hospitals
- Research Laboratories
Global Point of Care Diagnostics Market Based on Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America
- U.S.
- Canada
Europe
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Point of Care Diagnostics Market Size is valued at USD 16.25 Billion in 2025 and is predicted to reach USD 38.87 Billion by the year 2035.
Point of Care Diagnostics Market is expected to grow at an 9.60% CAGR during the forecast period for 2026-2035.
Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., J&J.
point of care diagnostics market can be segmented on the basis of products, Platform, mode of purchase, technology, sample type, end-users, and region.
North American region is leading the Point of Care Diagnostics Market.